OKYO Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for OKYO Pharma Limited (OKYO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Current Assets
Cash and Cash Equivalents1.560.834.052.705.010.190.482.01
Cash & Short-Term Investments1.560.834.052.705.010.190.482.01
Accounts Receivable1.890.580.980.880.060.000.000.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets0.230.130.170.710.000.000.000.00
Total Current Assets3.681.545.204.305.080.460.582.01
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.010.000.080.020.000.00
Other Non-Current Assets0.000.000.000.000.000.000.000.00
Total Non-Current Assets0.000.000.010.010.080.020.000.00
Total Assets3.681.545.203.275.160.480.582.01
Current Liabilities
Accounts Payable7.906.132.311.031.220.570.330.12
Short-Term Debt0.000.002.220.000.000.000.000.00
Accrued Liabilities0.381.191.880.611.460.000.000.00
Other Current Liabilities1.330.100.070.000.000.000.000.00
Total Current Liabilities9.237.427.261.351.240.570.330.09
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.050.020.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.050.020.000.00
Total Liabilities9.237.427.261.031.290.600.330.09
Stockholders' Equity
Common Stock0.00143.11131.39123.980.000.000.000.00
Retained Earnings-143.02-142.52-125.70-76.85-77.12-69.42-68.21-64.45
Accumulated Other Comprehensive Income-11.47-6.47-11.451.91-7.401.790.060.00
Additional Paid-in Capital0.000.000.0077.1867.1567.5268.4066.37
Shares Outstanding36.0233.3451.0421.140.000.000.000.00
Total Stockholders' Equity-5.55-5.88-2.052.243.87-0.110.261.92
Total Liabilities & Equity3.681.545.203.275.160.480.582.01